B-cell Acute Lymphoblastic Leukemia
Showing 26 - 50 of 62
B-cell Acute Lymphoblastic Leukemia Trial in Sanhe (GC007F)
Completed
- B-cell Acute Lymphoblastic Leukemia
- GC007F
-
Sanhe, Hebei, ChinaHebei Yanda Ludaopei Hospital
Apr 21, 2022
Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in United States (PBCAR0191, Fludarabine, Cyclophosphamide)
Recruiting
- Non-Hodgkin Lymphoma
- B-cell Acute Lymphoblastic Leukemia
- PBCAR0191
- +2 more
-
Duarte, California
- +9 more
Apr 18, 2022
B-cell Acute Lymphoblastic Leukemia, Lymphoblastic B-Cell Lymphoma Trial in Minsk (CD19 CAR-T-cells, Tocilizumab)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Lymphoblastic B-Cell Lymphoma
- CD19 CAR-T-cells
- Tocilizumab
-
Minsk, Minsk Region, BelarusBelarussian Research Center for Pediatric Oncology, Hematology a
Apr 12, 2022
B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin
Apr 4, 2022
Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United
Completed
- Acute Myelogenous Leukemia
- +3 more
- XmAb14045
-
Jacksonville, Florida
- +8 more
Mar 4, 2022
B-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CART/CTL and DCvac)
Recruiting
- B-Cell Acute Lymphoblastic Leukemia
- Antigen-specific T cells CART/CTL and DCvac
-
Shenzhen, Guangdong, ChinaShenzhen Geno-Immune Medical Institute
Mar 7, 2022
B-cell Acute Lymphoblastic Leukemia Trial in Seoul (SNUH-CD19-CAR-T)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- SNUH-CD19-CAR-T
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 20, 2022
B-cell Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel)
Withdrawn
- B-cell Acute Lymphoblastic Leukemia
- Tisagenlecleucel
- (no location specified)
Feb 3, 2022
Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)
Recruiting
- Lymphoma, Non-Hodgkin
- +9 more
- NKX019
-
Denver, Colorado
- +6 more
Jan 19, 2022
B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- ABL001
- +2 more
-
Chicago, Illinois
- +5 more
Dec 27, 2021
CAR T Cell Therapy Related Cardiovascular Outcomes
Recruiting
- Cardiovascular Diseases
- +7 more
-
London, United KingdomUniversity College London Hospitals
Nov 18, 2021
B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- Venetoclax
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 19, 2021
B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (UCART19)
Completed
- B-cell Acute Lymphoblastic Leukemia
- UCART19
-
Boston, Massachusetts
- +8 more
Sep 24, 2021
B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-Cell ALL, Childhood Trial in Milwaukee
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- Alpha/Beta T-cell and B-cell depleted HCT
- Blinatumomab
-
Milwaukee, WisconsinChildren's Hospital of Wisconsin
Sep 12, 2021
B-cell Acute Lymphoblastic Leukemia Trial in United States (NGS-MRD, Myeloablative allogeneic HCT with a non-TBI conditioning
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- NGS-MRD
- Myeloablative allogeneic HCT with a non-TBI conditioning regimen
-
Birmingham, Alabama
- +23 more
Aug 20, 2021
B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Kunming (Anti-CD19 CAR-T Cells Injection)
Recruiting
- B Cell Lymphoma
- B-cell Acute Lymphoblastic Leukemia
- Anti-CD19 CAR-T Cells Injection
-
Kunming, Yunnan, ChinaKunming Yan'an Hospital
May 12, 2021
B-cell Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Pediatric Trial in Moscow (Chimeric Antigen Receptor T-Cell
Unknown status
- B-cell Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia, Pediatric
- Chimeric Antigen Receptor T-Cell Therapy
- +3 more
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Apr 7, 2021
B Cell Leukemia, B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Guangzhou (CAR-ITNK cells)
Recruiting
- B Cell Leukemia
- +4 more
- CAR-ITNK cells
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 6, 2021
B Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic
Completed
- B Acute Lymphoblastic Leukemia
- +3 more
- AUTO3 (CD19/22 CAR T cells
-
London, United Kingdom
- +2 more
Jan 11, 2021
B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic
Completed
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CTL019 T-cells
-
Los Angeles, California
- +12 more
Oct 29, 2020
B-cell Acute Lymphoblastic Leukemia Trial (GC019F)
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia
- GC019F
- (no location specified)
Oct 14, 2020
B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (IFN-a combined with CAR-T cell therapy)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- IFN-α combined with CAR-T cell therapy
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Aug 28, 2020
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in ChongQing (anti-CD19 UCAR-T cells, Fludarabine, Cytoxan)
Unknown status
- B-cell Acute Lymphoblastic Leukemia
- B-cell Lymphoma
- anti-CD19 UCAR-T cells
- +3 more
-
ChongQing, Chongqing, ChinaDepartment of Hematology, Xinqiao Hospital
Feb 7, 2020
B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab)
Completed
- B-cell Acute Lymphoblastic Leukemia
-
Graz, Austria
- +74 more
Jan 31, 2020